- Home
- ABOS vs EML Comparison
ABOS vs EML Comparison
Compare ABOS & EML Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ABOS
- EML
- Stock Information
- Founded
- ABOS 1996
- EML 1858
- Country
- ABOS United States
- EML United States
- Employees
- ABOS N/A
- EML N/A
- Industry
- ABOS Biotechnology: Pharmaceutical Preparations
- EML Industrial Machinery/Components
- Sector
- ABOS Health Care
- EML Consumer Discretionary
- Exchange
- ABOS Nasdaq
- EML Nasdaq
- Market Cap
- ABOS 166.4M
- EML 171.1M
- IPO Year
- ABOS 2021
- EML N/A
- Fundamental
- Price
- ABOS $2.50
- EML $31.90
- Analyst Decision
- ABOS Strong Buy
- EML
- Analyst Count
- ABOS 4
- EML 0
- Target Price
- ABOS $9.00
- EML N/A
- AVG Volume (30 Days)
- ABOS 167.9K
- EML 33.4K
- Earning Date
- ABOS 11-11-2024
- EML 11-05-2024
- Dividend Yield
- ABOS N/A
- EML 1.40%
- EPS Growth
- ABOS N/A
- EML 65.47
- EPS
- ABOS N/A
- EML 1.92
- Revenue
- ABOS N/A
- EML $273,702,675.00
- Revenue This Year
- ABOS N/A
- EML N/A
- Revenue Next Year
- ABOS N/A
- EML N/A
- P/E Ratio
- ABOS N/A
- EML $16.56
- Revenue Growth
- ABOS N/A
- EML N/A
- 52 Week Low
- ABOS $1.81
- EML $16.10
- 52 Week High
- ABOS $5.09
- EML $35.78
- Technical
- Relative Strength Index (RSI)
- ABOS 46.15
- EML 62.55
- Support Level
- ABOS $2.44
- EML $29.73
- Resistance Level
- ABOS $2.66
- EML $32.70
- Average True Range (ATR)
- ABOS 0.15
- EML 1.10
- MACD
- ABOS 0.01
- EML 0.12
- Stochastic Oscillator
- ABOS 52.96
- EML 80.10
About ABOS Acumen Pharmaceuticals Inc.
Acumen Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing a novel disease-modifying approach to target what it believes to be a key underlying cause of Alzheimer's disease. The company's drug candidate, ACU193, is a subclass monoclonal antibody that selectively targets amyloid-beta oligomers.
About EML Eastern Company (The)
The Eastern Co manages industrial businesses that design, manufacture, and sell engineered solutions to industrial markets. The company manages the financial, operational, and strategic performance of its businesses to increase cash generation, operating earnings, and long-term shareholder value. It operates in the United States and Other Countries and generates the majority of its revenue from the United States.